{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T23:28:14Z","timestamp":1794353294211,"version":"4.9.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T00:00:00Z","timestamp":1783814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016996","name":"Ahmadu Bello University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016996","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Reports"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.toxrep.2026.102314","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T15:42:46Z","timestamp":1783957366000},"page":"102314","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Nigral biochemical and structural alterations following subacute exposure to MPTP in mice"],"prefix":"10.1016","volume":"17","author":[{"given":"R.","family":"Henry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.N.","family":"Agbon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.A.","family":"Musa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.B.","family":"Oladele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.toxrep.2026.102314_bib1","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/mds.29510","article-title":"Nigral pathology contributes to microstructural integrity of striatal and frontal tracts in Parkinson's disease","volume":"38","author":"Lin","year":"2023","journal-title":"Mov. Disord. Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.toxrep.2026.102314_bib2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41531-025-00911-6","article-title":"Nigrostriatal iron accumulation in the progression of Parkinson\u2019s disease","volume":"11","author":"L\u00f3pez-Aguirre","year":"2025","journal-title":"npj Parkinson's Dis."},{"issue":"6","key":"10.1016\/j.toxrep.2026.102314_bib3","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson's disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.toxrep.2026.102314_bib4","doi-asserted-by":"crossref","first-page":"431","DOI":"10.5115\/acb.24.034","article-title":"Honey and levodopa comparably preserved substantia nigra pars compacta neurons through the modulation of nuclear factor erythroid 2-related factor 2 signaling pathway in 1-methyl-4 phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson\u2019s disease model","volume":"57","author":"Sulaimon","year":"2024","journal-title":"Anat. Cell. Biol."},{"issue":"9","key":"10.1016\/j.toxrep.2026.102314_bib5","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1111\/j.1742-1241.2010.02371.x","article-title":"How should we treat a patient with early Parkinson\u2019s disease?","volume":"64","author":"Tsouli","year":"2010","journal-title":"Int. J. Clin. Pract."},{"issue":"8","key":"10.1016\/j.toxrep.2026.102314_bib6","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-017-1686-y","article-title":"Epidemiology of Parkinson's disease","volume":"124","author":"Tysnes","year":"2017","journal-title":"J. Neural Transm."},{"issue":"s1","key":"10.1016\/j.toxrep.2026.102314_bib7","first-page":"S3","article-title":"The emerging evidence of the Parkinson pandemic","volume":"8","author":"Dorsey","year":"2018","journal-title":"J. Park. \u2019S. Dis."},{"issue":"7","key":"10.1016\/j.toxrep.2026.102314_bib8","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/j.1742-4658.2012.08491.x","article-title":"Animal models of Parkinson\u2019s disease","volume":"279","author":"Blandini","year":"2012","journal-title":"FEBS J."},{"key":"10.1016\/j.toxrep.2026.102314_bib9","article-title":"Oxidative stress: a new pathophysiological pathway in Parkinson\u2019s disease and a potential target of the brain-sport crosstalk","volume":"2025","author":"Caproni","year":"2025","journal-title":"Parkinson's Dis."},{"issue":"1","key":"10.1016\/j.toxrep.2026.102314_bib10","doi-asserted-by":"crossref","DOI":"10.1080\/21688370.2025.2537991","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson's disease: mechanisms, biomarkers, and therapeutic strategies","volume":"14","author":"Usha Kiran","year":"2026","journal-title":"Tissue Barriers"},{"issue":"12","key":"10.1016\/j.toxrep.2026.102314_bib11","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson\u2019s disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"issue":"11","key":"10.1016\/j.toxrep.2026.102314_bib12","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3109\/13880209.2014.993041","article-title":"Ferulic acid pretreatment mitigates MPTP-induced motor impairment and histopathological alterations in C57BL\/6 mice","volume":"53","author":"Nagarajan","year":"2015","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.toxrep.2026.102314_bib13","doi-asserted-by":"crossref","DOI":"10.1177\/1759091418777438","article-title":"Neurotoxin-induced animal models of Parkinson disease: pathogenic mechanism and assessment","volume":"10","author":"Zeng","year":"2018","journal-title":"ASN Neuro"},{"issue":"10","key":"10.1016\/j.toxrep.2026.102314_bib14","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1021\/acschemneuro.9b00291","article-title":"GFR-\u03b11 expression in substantia nigra increases bilaterally following unilateral striatal GDNF in aged rats and attenuates nigral tyrosine hydroxylase loss following 6-OHDA nigrostriatal lesion","volume":"10","author":"Kasanga","year":"2019","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.toxrep.2026.102314_bib15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s12640-019-00097-9","article-title":"Early postnatal exposure to paraquat and maneb in mice increases nigrostriatal dopaminergic susceptibility to a re-challenge with the same pesticides at adulthood: Implications for Parkinson\u2019s disease","volume":"37","author":"Colle","year":"2020","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.toxrep.2026.102314_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jchemneu.2016.11.009","article-title":"Mucuna pruriens reduces inducible nitric oxide synthase expression in Parkinsonian mice model","volume":"80","author":"Yadav","year":"2017","journal-title":"J. Chem. Neuroanat."},{"issue":"4","key":"10.1016\/j.toxrep.2026.102314_bib17","first-page":"422","article-title":"MPTP-induced mouse model of Parkinson's disease: a promising direction of therapeutic strategies","volume":"21","author":"Mustapha","year":"2021","journal-title":"Bosn. J. Basic. Med. Sci."},{"issue":"3","key":"10.1016\/j.toxrep.2026.102314_bib18","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/BF03036449","article-title":"MPTP and SNpc DA neuronal vulnerability: Role of dopamine, superoxide, and nitric oxide in neurotoxicity","volume":"7","author":"Jackson-Lewis","year":"2005","journal-title":"Neurotox. Res."},{"issue":"8","key":"10.1016\/j.toxrep.2026.102314_bib19","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3390\/antiox9080647","article-title":"Mitochondrial dysfunction, oxidative stress, and neuroinflammation: intertwined roads to neurodegeneration","volume":"9","author":"Picca","year":"2020","journal-title":"Antioxidants"},{"issue":"3","key":"10.1016\/j.toxrep.2026.102314_bib20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0165-1781(79)90006-4","article-title":"Chronic parkinsonism secondary to intravenous injection of meperidine analogs","volume":"1","author":"Davis","year":"1979","journal-title":"Psychiatry Res."},{"issue":"5646","key":"10.1016\/j.toxrep.2026.102314_bib21","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1087753","article-title":"Molecular pathways of neurodegeneration in Parkinson\u2019s disease","volume":"302","author":"Dawson","year":"2000","journal-title":"Science"},{"issue":"5985","key":"10.1016\/j.toxrep.2026.102314_bib22","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/311464a0","article-title":"Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism","volume":"311","author":"Markey","year":"1984","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.toxrep.2026.102314_bib23","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3233\/JPD-2011-11023","article-title":"MPTP mouse models of Parkinson\u2019s disease: an update","volume":"1","author":"Meredith","year":"2011","journal-title":"J. Parkinson's Dis."},{"issue":"1","key":"10.1016\/j.toxrep.2026.102314_bib24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson's disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat. Protoc."},{"issue":"2","key":"10.1016\/j.toxrep.2026.102314_bib25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0006-8993(00)02778-5","article-title":"Efficient testing of motor function in spinal cord injured rats","volume":"883","author":"Metz","year":"2000","journal-title":"Brain Res."},{"issue":"12","key":"10.1016\/j.toxrep.2026.102314_bib26","first-page":"1","article-title":"Motor coordination and balance in rodents","volume":"8","author":"Carter","year":"2001","journal-title":"Curr. Protoc. Neurosci."},{"issue":"2","key":"10.1016\/j.toxrep.2026.102314_bib27","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.bbr.2006.11.042","article-title":"Adaptation of a ladder beam walking task to assess locomotor recovery in mice following spinal cord injury","volume":"177","author":"Cummings","year":"2007","journal-title":"Behav. Brain Res."},{"issue":"4","key":"10.1016\/j.toxrep.2026.102314_bib28","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1590\/S1516-89132009000400012","article-title":"Moxidectin interference on motor activity of rats","volume":"52","author":"Rodrigues-Alves","year":"2009","journal-title":"Braz. Arch. Biol. Technol."},{"key":"10.1016\/j.toxrep.2026.102314_bib29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0165-0270(96)02211-X","article-title":"Pole test is a useful method for evaluating the mouse movement disorder caused by striatal dopamine depletion","volume":"73","author":"Matsuura","year":"1997","journal-title":"J. Neurosci. Methods"},{"issue":"9","key":"10.1016\/j.toxrep.2026.102314_bib30","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/aps.2017.49","article-title":"Reassessment of subacute MPTP-treated mice as an animal model of Parkinson\u2019s disease","volume":"38","author":"Zhang","year":"2017","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.toxrep.2026.102314_bib31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12906-015-0675-7","article-title":"Neuroprotective effects of Eucommia ulmoides Oliv. and its bioactive constituents work via ameliorating the ubiquitin\u2013proteasome system","volume":"15","author":"Guo","year":"2015","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.toxrep.2026.102314_bib32","doi-asserted-by":"crossref","first-page":"565","DOI":"10.2147\/DDDT.S156920","article-title":"Vitexin protects dopaminergic neurons in MPTP-induced Parkinson\u2019s disease through PI3K\/Akt signaling pathway","volume":"12","author":"Hu","year":"2018","journal-title":"Drug. Des. Dev. Ther."},{"issue":"2","key":"10.1016\/j.toxrep.2026.102314_bib33","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.pathophys.2017.02.001","article-title":"Ceftriaxone attenuates glutamate-mediated neuro-inflammation and restores BDNF in MPTP model of Parkinson\u2019s disease in rats","volume":"24","author":"Kaur","year":"2017","journal-title":"Pathophysiology"},{"issue":"6","key":"10.1016\/j.toxrep.2026.102314_bib34","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0100395","article-title":"Identification of licopyranocoumarin and glycyrurol from herbal medicines as neuroprotective compounds for Parkinson's disease","volume":"9","author":"Fujimaki","year":"2014","journal-title":"PLoS. ONE"},{"issue":"1","key":"10.1016\/j.toxrep.2026.102314_bib35","doi-asserted-by":"crossref","first-page":"2","DOI":"10.31083\/j.jin2301002","article-title":"Levodopa improves behavioral deficits of mice with Parkinson's disease symptoms via curbing NLRP3 inflammasome activation and enhancing tyrosine hydroxylase levels in the striatum and substantia nigra","volume":"23","author":"Chen","year":"2024","journal-title":"J. Integr. Neurosci."},{"issue":"4","key":"10.1016\/j.toxrep.2026.102314_bib36","doi-asserted-by":"crossref","first-page":"154","DOI":"10.5582\/ddt.2022.01026","article-title":"Effects of eugenol on the behavioral and pathological progression in the MPTP-induced Parkinson's disease mouse model","volume":"16","author":"Vora","year":"2022","journal-title":"Drug. Discov. Ther."},{"issue":"1","key":"10.1016\/j.toxrep.2026.102314_bib37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jphs.2018.08.008","article-title":"Neuroprotective effects of pramipexole transdermal patch in the MPTP-induced mouse model of Parkinson\u2019s disease","volume":"138","author":"Wang","year":"2018","journal-title":"J. Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.toxrep.2026.102314_bib38","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1080\/15376516.2024.2364191","article-title":"Neuroprotective effect of marrubiin against MPTP-induced experimental Parkinson\u2019s disease in male Wistar rats","volume":"34","author":"Xu","year":"2024","journal-title":"Toxicol. Mech. Methods"},{"issue":"4","key":"10.1016\/j.toxrep.2026.102314_bib39","first-page":"1227","article-title":"Cerebellar vs. cerebral neurodegeneration: MPTP-induced Parkinson\u2019s disease model in Swiss albino mice","volume":"11","author":"Kanika","year":"2024","journal-title":"J. Neurol. Disord. Stroke"},{"issue":"1","key":"10.1016\/j.toxrep.2026.102314_bib40","doi-asserted-by":"crossref","first-page":"49","DOI":"10.17576\/jsm-2024-5301-05","article-title":"MPTP-induced BALB\/C mice recapitulate compensatory Parkinson\u2019s-like motor","volume":"53","author":"Mustapha","year":"2024","journal-title":"Sains Malays."},{"key":"10.1016\/j.toxrep.2026.102314_bib41","first-page":"310","article-title":"Diagnosis and assessment of Parkinson's disease and other movement disorders","volume":"24","author":"Jankovic","year":"2021","journal-title":"Bradley's. Neurol. Clin. Pract."},{"issue":"1","key":"10.1016\/j.toxrep.2026.102314_bib42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/jnbs.jnbs_1_22","article-title":"Motor function test protocol for parkinsonian triad in rodent model of Parkinson's disease","volume":"9","author":"Sirajo","year":"2022","journal-title":"J. Neurobehav. Sci."},{"key":"10.1016\/j.toxrep.2026.102314_bib43","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s42826-019-0012-2","article-title":"Comparative analysis of dose-dependent neurotoxic response to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL\/6N mice derived from three different sources","volume":"35","author":"Hwang","year":"2019","journal-title":"Lab. Anim. Res."},{"issue":"8","key":"10.1016\/j.toxrep.2026.102314_bib44","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1007\/s11011-021-00840-2","article-title":"Impaired mitochondrial functions and energy metabolism in MPTP-induced Parkinson's disease: comparison of mice strains and dose regimens","volume":"36","author":"Pathania","year":"2021","journal-title":"Metab. Brain Dis."},{"issue":"9","key":"10.1016\/j.toxrep.2026.102314_bib45","doi-asserted-by":"crossref","first-page":"916","DOI":"10.3390\/brainsci15090916","article-title":"Therapeutic Botulinum Neurotoxin ameliorates motor deficits and anxiety, accompanied by dopaminergic neuroprotection and diminished microglia burden in the MPTP-induced mouse model of Parkinson\u2019s disease","volume":"15","author":"Joseph","year":"2025","journal-title":"Brain Sci."},{"key":"10.1016\/j.toxrep.2026.102314_bib46","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.2147\/NDT.S299685","article-title":"Neuroprotective effects and related mechanisms of echinacoside in MPTP-induced PD mice","volume":"17","author":"Zhang","year":"2021","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.toxrep.2026.102314_bib47","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/845618","article-title":"Classic and new animal models of Parkinson's disease","volume":"2012","author":"Blesa","year":"2012","journal-title":"J. Biomed. Biotechnol."},{"issue":"4","key":"10.1016\/j.toxrep.2026.102314_bib48","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JPD-130230","article-title":"The role of oxidative stress in Parkinson's disease","volume":"3","author":"Dias","year":"2013","journal-title":"J. Parkinson's Dis."},{"issue":"6","key":"10.1016\/j.toxrep.2026.102314_bib49","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"L\u00f3pez-Ot\u00edn","year":"2013","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.toxrep.2026.102314_bib50","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00702-016-1616-4","article-title":"Gene therapy targeting mitochondrial pathway in Parkinson\u2019s disease","volume":"124","author":"Choong","year":"2017","journal-title":"J. Neural Transm."},{"issue":"3","key":"10.1016\/j.toxrep.2026.102314_bib51","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.37212\/jcnos.1574037","article-title":"Ginkgolide B ameliorates MPTP-induced neuroinflammation and neurodegeneration by improving mitochondrial electron transport chain complex I","volume":"16","author":"Praveen","year":"2024","journal-title":"J. Cell. Neurosci. Oxid. Stress."},{"key":"10.1016\/j.toxrep.2026.102314_bib52","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12575-024-00236-3","article-title":"Targeting mitochondrial complex I deficiency in MPP\u207a\/MPTP-induced Parkinson\u2019s disease cell culture and mouse models by transducing yeast NDI1 gene","volume":"26","author":"Li","year":"2024","journal-title":"Biol. Proced. Online"},{"key":"10.1016\/j.toxrep.2026.102314_bib53","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/j.1471-4159.2012.07815.x","article-title":"MPTP modulates hippocampal synaptic transmission and activity-dependent synaptic plasticity via dopamine receptors","volume":"122","author":"Zhu","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.toxrep.2026.102314_bib54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11055-024-01560-7","article-title":"Beneficial role of capsaicin through modulation of mitochondrial functions in MPTP-injected mice","volume":"55","author":"Tyagi","year":"2025","journal-title":"Neurosci. Behav. Physiol."},{"issue":"2","key":"10.1016\/j.toxrep.2026.102314_bib55","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3390\/ijms17020151","article-title":"Microglia-mediated neuroinflammation and neurotrophic factor-induced protection in the MPTP mouse model of Parkinson\u2019s disease\u2013Lessons from transgenic mice","volume":"17","author":"Machado","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.toxrep.2026.102314_bib56","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neulet.2017.10.014","article-title":"Inhibition of BDNF production by MPP\u207a through up-regulation of miR-210-3p contributes to dopaminergic neuron damage in MPTP model","volume":"675","author":"Zhang","year":"2018","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.toxrep.2026.102314_bib57","article-title":"Feruloylated oligosaccharides ameliorate MPTP-induced neurotoxicity in mice by activating ERK\/CREB\/BDNF\/TrkB signalling pathway","volume":"104","author":"Ding","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.toxrep.2026.102314_bib58","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2025.1573674","article-title":"Effect of Baduanjin exercise in a blended online-offline model on cognitive function and peripheral blood BDNF levels in older adults","volume":"16","author":"Zhou","year":"2025","journal-title":"Front. Physiol."},{"key":"10.1016\/j.toxrep.2026.102314_bib59","article-title":"The role of BDNF\/PI3K\/AKT\/Nrf2 signaling in nicotine\u2019s protective effects against MPTP-induced Parkinson\u2019s disease","volume":"162","author":"Zhgenti","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.toxrep.2026.102314_bib60","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.neuroscience.2025.03.050","article-title":"Chenodeoxycholic acid-mediated neuroprotection via \u03b1-synuclein and BDNF modulation in an MPTP-induced mouse model of Parkinson\u2019s disease","volume":"573","author":"Mehreen","year":"2025","journal-title":"Neuroscience"},{"key":"10.1016\/j.toxrep.2026.102314_bib61","first-page":"498","article-title":"Oksydaza monoaminowa jako miejsce dzia\u0142ania lek\u00f3w [Monoamine oxidase as a site of drug action]","volume":"60","author":"Dro\u017cak","year":"2006","journal-title":"Post\u0119py Higieny i Medycyny Do\u015bwiadczalnej"},{"key":"10.1016\/j.toxrep.2026.102314_bib62","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.neulet.2016.01.048","article-title":"Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson\u2019s disease: Involvement of the dopamine system","volume":"616","author":"Guo","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.toxrep.2026.102314_bib63","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1007\/s00044-025-03409-1","article-title":"Unrevealing the molecular mechanisms of MPTP-induced Parkinson\u2019s in experimental animals","volume":"34","author":"Mondal","year":"2025","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.toxrep.2026.102314_bib64","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12640-025-00732-8","article-title":"Restoration of MPTP-induced dopamine and tyrosine hydroxylase depletion in the mouse brain through ethanol and nicotine","volume":"43","author":"Jamal","year":"2025","journal-title":"Neurotox. Res."},{"issue":"1\u20132","key":"10.1016\/j.toxrep.2026.102314_bib65","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0166-4328(02)00087-6","article-title":"Relationships between various behavioural abnormalities and nigrostriatal dopamine depletion in the unilateral 6-OHDA-lesioned rat","volume":"139","author":"Henderson","year":"2003","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.toxrep.2026.102314_bib66","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bbr.2005.04.011","article-title":"Swim-test as a function of motor impairment in MPTP model of Parkinson\u2019s disease: a comparative study in two mouse strains","volume":"163","author":"Haobam","year":"2005","journal-title":"Behav. Brain Res."},{"issue":". 1","key":"10.1016\/j.toxrep.2026.102314_bib67","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.3233\/JPD-179006","article-title":"The MPTP story","volume":"7","author":"Langston","year":"2017","journal-title":"J. Parkinson\u2019s Dis."},{"issue":"1","key":"10.1016\/j.toxrep.2026.102314_bib68","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/mdc3.13344","article-title":"MPTP Parkinsonism and implications for understanding Parkinson's disease","volume":"9","author":"AlShimemeri","year":"2021","journal-title":"Mov. Disord. Clin. Pract."}],"container-title":["Toxicology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750026001162?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750026001162?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:40:01Z","timestamp":1794350401000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214750026001162"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":68,"alternative-id":["S2214750026001162"],"URL":"https:\/\/doi.org\/10.1016\/j.toxrep.2026.102314","relation":{},"ISSN":["2214-7500"],"issn-type":[{"value":"2214-7500","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nigral biochemical and structural alterations following subacute exposure to MPTP in mice","name":"articletitle","label":"Article Title"},{"value":"Toxicology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxrep.2026.102314","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102314"}}